Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Natera stock
Learn how to easily invest in Natera stock.
Natera Inc is a diagnostics & research business based in the US. Natera shares (NTRA) are listed on the NASDAQ and all prices are listed in US Dollars. Natera employs 2,670 staff and has a trailing 12-month revenue of around $723.5 million.
How to buy shares in Natera
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NTRA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Natera stock price (NASDAQ: NTRA)Use our graph to track the performance of NTRA stocks over time.
Natera shares at a glance
|Latest market close||$44.47|
|52-week range||$26.10 - $121.05|
|50-day moving average||$49.45|
|200-day moving average||$52.07|
|Wall St. target price||$84.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-5.89|
Buy Natera shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Natera stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Natera price performance over time
|1 week (2022-09-19)||-9.04%|
|1 month (2022-08-26)||-8.38%|
|3 months (2022-06-28)||17.90%|
|6 months (2022-03-26)||N/A|
|1 year (2021-09-30)||-60.10%|
|2 years (2020-09-30)||-38.44%|
|3 years (2019-09-30)||35.58%|
|5 years (2017-09-29)||245.00%|
|Revenue TTM||$723.5 million|
|Gross profit TTM||$307.1 million|
|Return on assets TTM||-37.17%|
|Return on equity TTM||-154.79%|
|Market capitalisation||$4.2 billion|
TTM: trailing 12 months
Natera share dividends
We're not expecting Natera to pay a dividend over the next 12 months.
Natera share price volatility
Over the last 12 months, Natera's shares have ranged in value from as little as $26.1 up to $121.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Natera's is 1.332. This would suggest that Natera's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Natera, Inc. , a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co.
Natera in the news
Natera Announces 2025 ESG Goals with Publication of 2021 Report
Natera Presents New Colorectal and Breast Cancer Data at ESMO 2022, Highlighting Signatera's Ability to Inform Treatment Decisions in the Adjuvant and Neoadjuvant Settings
Natera to Participate in Upcoming Investor Conferences
Frequently asked questionsWhat percentage of Natera is owned by insiders or institutions?
Currently 3.769% of Natera shares are held by insiders and 96.954% by institutions. How many people work for Natera?
Latest data suggests 2,670 work at Natera. When does the fiscal year end for Natera?
Natera's fiscal year ends in December. Where is Natera based?
Natera's address is: 13011 McCallen Pass Building A, San Carlos, CA, United States, 78753 What is Natera's ISIN number?
Natera's international securities identification number is: US6323071042 What is Natera's CUSIP number?
Natera's Committee on Uniform Securities Identification Procedures number is: 632307104
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert